Endometrioma Clinical Trial
Official title:
Effect of Laparoscopic Ovarian Cystectomy of Endometrioma Versus Cyst Deroofing on Ovarian Reserve as Determined by Anti-mullerian Hormone and Antral Follicle Count: a Prospective Randomized Study.
Verified date | March 2015 |
Source | Ain Shams University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Egypt: Institutional Review Board |
Study type | Interventional |
The purpose of this study is to evaluate the impact of laparoscopic ovarian cystectomy versus laparoscopic cyst deroofing on ovarian reserve measured by serum levels of anti mullerian hormone and antral follicle count in patients with endometriomas.
Status | Completed |
Enrollment | 122 |
Est. completion date | August 2014 |
Est. primary completion date | August 2014 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: 1. Age from 18-35 year 2. Regular menstrual cycles. 3. Endometrioma (unilateral or bilateral) diagnosed by transvaginal ultrasound with diameter = 3 cm. Exclusion criteria: 1. Any previous ovarian surgery. 2. Evidence of polycystic ovary syndrome according to Rotterdam criteria -Two of three of: - Oligo- or chronic anovulation. - Clinical and/or biochemical signs of hyperandrogenism. - Polycystic ovaries. 3. Evidence of premature ovarian failure diagnosed by follicle stimulating hormone level =40 IU/L 4. Any endocrinal disease affecting ovarian function e.g. thyroid dysfunction, hyperprolactinemia. 5. Previous hormonal medications e.g. oral contraceptive pills, gonadotropin-releasing hormone analogue within the last 3 months before surgery. 6. Any suspicious findings of ovarian malignant diseases diagnosed by transvaginal ultrasound. 7. Contraindication to surgery. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
Egypt | Ain Shams University Maternity Hospital | Cairo |
Lead Sponsor | Collaborator |
---|---|
Ain Shams University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | comparison between the impacts of laparoscopic ovarian cystectomy and laparoscopic cyst deroofing on ovarian reserve as determined by alteration of AMH level in endometrioma patients. | 17 months | No | |
Secondary | comparison between the impacts of laparoscopic ovarian cystectomy and laparoscopic cyst deroofing on ovarian reserve as determined by antral follicle count estimation in endometrioma patients. | 17 months | No | |
Secondary | comparison between the impacts of laparoscopic ovarian cystectomy and laparoscopic cyst deroofing on ovarian reserve as determined by ovarian volume estimation in endometrioma patients. | 17 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01268930 -
Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas
|
N/A | |
Completed |
NCT05323539 -
Comparison of Thyroid Volumes in Patients With and Without Endometrioma
|
N/A | |
Recruiting |
NCT04178876 -
Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( CLESS)
|
N/A | |
Completed |
NCT06421857 -
Hemostatic Measures During Laparoscopic Cystectomy for Endometrioma
|
N/A | |
Recruiting |
NCT04151433 -
Conservative Endometrioma Surgery
|
N/A | |
Completed |
NCT01942122 -
DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis
|
Phase 2/Phase 3 | |
Withdrawn |
NCT00999479 -
Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation
|
N/A | |
Recruiting |
NCT03687398 -
Genomic Maps of Endometrial Tissues of Patients With Endometriosis and Healthy Controls
|
||
Not yet recruiting |
NCT06377553 -
PET/MRI for Evaluation of Endometriosis
|
||
Not yet recruiting |
NCT03788720 -
Suture of the Ovary After Enucleation of Ovarian Endometrioma
|
N/A | |
Completed |
NCT01982526 -
Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients
|
||
Recruiting |
NCT05962775 -
Ethanol Sclerotherapy Prior to ART
|
N/A | |
Completed |
NCT03484546 -
Optimum Menstrual Cycle Time for Endometrioma Excision
|
||
Recruiting |
NCT05637073 -
Effect of Management of the Endometrioma on Ovarian Reserve
|
||
Completed |
NCT06219044 -
Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization
|
N/A | |
Recruiting |
NCT03620838 -
Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
|
||
Terminated |
NCT03571776 -
Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial
|
N/A | |
Enrolling by invitation |
NCT02472873 -
Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas
|
N/A | |
Completed |
NCT04941833 -
Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo
|
Phase 2/Phase 3 | |
Completed |
NCT06274086 -
Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma
|
N/A |